Colin Downey, Ph.D. - Blogs | Oblon Life Sciences Blog

AUTHORS

Richard D. Kelly
rkelly@oblon.com
(703) 412-6241

Marina I. Miller, Ph.D.
mmiller@oblon.com
(703) 412-6044

Daniel J. Pereira, Ph.D.
dpereira@oblon.com
(703) 413-6560

Yuki Onoe
yonoe@oblon.com
+81-3-6212-0550

Grace Kim
gkim@oblon.com
(703) 412-1425

Derek Lightner, Ph.D.
dlightner@oblon.com
(703) 236-2680

Sara Pistilli, PharmD.
spistilli@oblon.com
(703) 412-1784

Colin Downey, Ph.D.
cdowney@oblon.com
(703) 412-2933

No matches found...

ACCOLADES

View Accolades

CATEGORIES

Pharma Alice Standard Federal Circuit USPTO PTAB Rules Cannabis Supreme Court Patent Eligibility 101 Mayo Myriad Gene Segments IPR Antibodies AI Artificial Intelligence Life Cycle Management

STAY UPDATED

Copyright © Oblon, McClelland, Maier & Neustadt, L.L.P. | Disclaimer

The opinions, commentary and characterizations provided to this online forum by the authors and moderators are provided for encouraging discussion, thought and debate on important design patent issues. These postings are in no way representative of the opinions of the Oblon firm, or its clients, but rather the personal views of the individual authors.

Hosted on the FirmWise platform.